Sir,
We read this case report with interest and would like to raise the following points.
It would be impossible to conclude that BMP-7 was responsible for
union in this recalcitrant case as autologous bone was concomitantly packed
into the non-union site at the time of operation. Certainly BMP-7 was
shown to be as effective as autogenic bone graft in a comparative trial
for cases of tibial non-union,1 however, unless this is shown in the
treatment of congenital pseudarthrosis in a similar fashion it will remain
an unassessed expensive adjunct of indeterminate efficacy.
The authors also described how the affected leg refractured
repeatedly after removal of either the protective cast or the
intramedullary rods. It is customary to maintain protection of the
operated limb with an external brace until the medullary canal reforms.2
It is the practice in our institution to maintain the intramedullary
rod fixation certainly up until skeletal maturity. The intramedullary
device provides internal splinting for the maturing bone and we have found
that refracture or recurrent bowing of the tibia can occur 3 upon its
premature removal, leaving the affected limb unaccommodating to any further
treatment.
S.L.Bali,
C.Tilkeridis,
Rowley Bristow Orthopaedic Centre,
St. Peter’s Hospital,
Chertsey, UK.
1. Friedlander GE, Perry CR, Cole JD, et al. Osteogenic protein-1 (bone
morphogenetic protein-7) in the treatment of tibial nonunions.J Bone Joint Surg [Am] 2001;83-A Suppl 1(Pt 2):S151-8.
2. Umber JS, Moss SW, Coleman SS. Surgical treatment of congenital
pseudarthrosis of the tibia. Clin Orth Rel Res
1982;168:28-33.
3. Paterson DC, Simonis RB. Electrical stimulation in the treatment
of congenital pseudarthrosis of the tibia. J Bone Joint
Surg [Br] 1985;67-B:454-62.